You are here: Home / Our people / Our people / Academic staff list / Dr Belinda Gray 

Dr Belinda Gray

Clinical Lecturer
Central Clinical School

Telephone +61 2 9565 6295

Map

Selected grants

2016

  • Visit to Prof Silvia Priori's Molecular Cardiology Laboratory, New York USA; Gray B; National Heart Foundation of Australia/Collaboration and Exchange Award.

2015

  • Cardiovascular Effects of Energy Drinks; Gray B, Semsarian C, Driscoll T; National Heart Foundation of Australia/Vanguard Grant.
Back to Top

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Gray, B., Bagnall, R., Lam, L., Ingles, J., Turner, C., Haan, E., Davis, A., Yang, P., Clancy, C., Sy, R., Semsarian, C. (2016). A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm, 13(8), 1652-1660. [More Information]
  • Gray, B., Klimis, H., Inam, S., Ariyathna, N., Kumar, S., Bailey, B., Patel, S. (2016). Corrigendum to 'Radiation Exposure During Cardiac Catheterisation is Similar for Both Femoral and Radial Approaches' Heart, Lung and Circulation (2015) 24, 264-269. Heart, Lung and Circulation, 25(10), 1043. [More Information]
  • Gray, B., Behr, E. (2016). New Insights into the Genetic Basis of Inherited Arrhythmia Syndromes. Circulation: Cardiovascular Genetics, 9(6), 569-577. [More Information]
  • Earle, N., Ingles, J., Bagnall, R., Gray, B., Crawford, J., Smith, W., Shelling, A., Love, D., Semsarian, C., Skinner, J. (2015). NOS1AP polymorphisms modify QTc interval duration but not cardiac arrest risk in hypertrophic cardiomyopathy. Journal of Cardiovascular Electrophysiology. [More Information]
  • Gray, B., Klimis, H., Inam, S., Ariyathna, N., Kumar, S., Bailey, B., Patel, S. (2015). Radiation Exposure During Cardiac Catheterisation is Similar for Both Femoral and Radial Approaches. Heart, Lung and Circulation, 24(3), 264-269. [More Information]
  • Ingles, J., Johnson, R., Sarina, T., Yeates, L., Burns, C., Gray, B., Ball, K., Semsarian, C. (2015). Social determinants of health in the setting of hypertrophic cardiomyopathy. International Journal of Cardiology, 184(1), 743-749. [More Information]
  • Gray, B., Semsarian, C., Sy, R. (2014). Brugada Syndrome: A Heterogeneous Disease with a Common ECG Phenotype? Journal of Cardiovascular Electrophysiology, 25(4), 450-456. [More Information]
  • Puranik, R., Gray, B., Lackey, H., Yeates, L., Parker, G., Duflou, J., Semsarian, C. (2014). Comparison of conventional autopsy and magnetic resonance imaging in determining the cause of sudden death in the young. Journal of Cardiovascular Magnetic Resonance, 16(1), 1-11. [More Information]
  • Gray, B., McGuire, M., Semsarian, C., Medi, C. (2014). Late positive flecainide challenge test for Brugada syndrome. Heart Rhythm, 11(5), 898-900. [More Information]
  • Gray, B., Spies, J., Ng, M. (2014). Severe hypertensive encephalopathy following percutaneous balloon aortic valvuloplasty for aortic stenosis. International Journal of Cardiology, 171(3), e63-e64. [More Information]
  • Yu, Y., Gray, B., Lowe, H., Halmagyi, G., Ng, M. (2013). Dual modality intravascular imaging of unstable, symptomatic but "hemodynamically insignificant" carotid stenosis. Journal of Neurology, 260(7), 1934-1935. [More Information]
  • Gray, B., Yeates, L., Medi, C., Ingles, J., Semsarian, C. (2013). Homozygous mutation in the cardiac troponin I gene: Clinical heterogeneity in hypertrophic cardiomyopathy. International Journal of Cardiology, 168(2), 1530-1531. [More Information]
  • Gray, B., Ingles, J., Medi, C., Semsarian, C. (2013). Prolongation of the QTc Interval Predicts Appropriate Implantable Cardioverter-Defibrillator Therapies in Hypertrophic Cardiomyopathy. JACC: Heart Failure, 1(2), 149-155. [More Information]
  • Gray, B., Das K, J., Semsarian, C. (2012). Consumption of energy drinks: A new provocation test for primary arrhythmogenic diseases? International Journal of Cardiology, 159(1), 77-78. [More Information]
  • Gray, B., Ingles, J., Semsarian, C. (2011). Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy. International Journal of Cardiology, 152(2), 258-259. [More Information]
  • Gray, B., MacDonald, P., Kuchar, D. (2011). Reversal of cardiomyopathy with ivabradine. Internal Medicine Journal, 41(2), 213-214. [More Information]

2016

  • Gray, B., Bagnall, R., Lam, L., Ingles, J., Turner, C., Haan, E., Davis, A., Yang, P., Clancy, C., Sy, R., Semsarian, C. (2016). A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm, 13(8), 1652-1660. [More Information]
  • Gray, B., Klimis, H., Inam, S., Ariyathna, N., Kumar, S., Bailey, B., Patel, S. (2016). Corrigendum to 'Radiation Exposure During Cardiac Catheterisation is Similar for Both Femoral and Radial Approaches' Heart, Lung and Circulation (2015) 24, 264-269. Heart, Lung and Circulation, 25(10), 1043. [More Information]
  • Gray, B., Behr, E. (2016). New Insights into the Genetic Basis of Inherited Arrhythmia Syndromes. Circulation: Cardiovascular Genetics, 9(6), 569-577. [More Information]

2015

  • Earle, N., Ingles, J., Bagnall, R., Gray, B., Crawford, J., Smith, W., Shelling, A., Love, D., Semsarian, C., Skinner, J. (2015). NOS1AP polymorphisms modify QTc interval duration but not cardiac arrest risk in hypertrophic cardiomyopathy. Journal of Cardiovascular Electrophysiology. [More Information]
  • Gray, B., Klimis, H., Inam, S., Ariyathna, N., Kumar, S., Bailey, B., Patel, S. (2015). Radiation Exposure During Cardiac Catheterisation is Similar for Both Femoral and Radial Approaches. Heart, Lung and Circulation, 24(3), 264-269. [More Information]
  • Ingles, J., Johnson, R., Sarina, T., Yeates, L., Burns, C., Gray, B., Ball, K., Semsarian, C. (2015). Social determinants of health in the setting of hypertrophic cardiomyopathy. International Journal of Cardiology, 184(1), 743-749. [More Information]

2014

  • Gray, B., Semsarian, C., Sy, R. (2014). Brugada Syndrome: A Heterogeneous Disease with a Common ECG Phenotype? Journal of Cardiovascular Electrophysiology, 25(4), 450-456. [More Information]
  • Puranik, R., Gray, B., Lackey, H., Yeates, L., Parker, G., Duflou, J., Semsarian, C. (2014). Comparison of conventional autopsy and magnetic resonance imaging in determining the cause of sudden death in the young. Journal of Cardiovascular Magnetic Resonance, 16(1), 1-11. [More Information]
  • Gray, B., McGuire, M., Semsarian, C., Medi, C. (2014). Late positive flecainide challenge test for Brugada syndrome. Heart Rhythm, 11(5), 898-900. [More Information]
  • Gray, B., Spies, J., Ng, M. (2014). Severe hypertensive encephalopathy following percutaneous balloon aortic valvuloplasty for aortic stenosis. International Journal of Cardiology, 171(3), e63-e64. [More Information]

2013

  • Yu, Y., Gray, B., Lowe, H., Halmagyi, G., Ng, M. (2013). Dual modality intravascular imaging of unstable, symptomatic but "hemodynamically insignificant" carotid stenosis. Journal of Neurology, 260(7), 1934-1935. [More Information]
  • Gray, B., Yeates, L., Medi, C., Ingles, J., Semsarian, C. (2013). Homozygous mutation in the cardiac troponin I gene: Clinical heterogeneity in hypertrophic cardiomyopathy. International Journal of Cardiology, 168(2), 1530-1531. [More Information]
  • Gray, B., Ingles, J., Medi, C., Semsarian, C. (2013). Prolongation of the QTc Interval Predicts Appropriate Implantable Cardioverter-Defibrillator Therapies in Hypertrophic Cardiomyopathy. JACC: Heart Failure, 1(2), 149-155. [More Information]

2012

  • Gray, B., Das K, J., Semsarian, C. (2012). Consumption of energy drinks: A new provocation test for primary arrhythmogenic diseases? International Journal of Cardiology, 159(1), 77-78. [More Information]

2011

  • Gray, B., Ingles, J., Semsarian, C. (2011). Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy. International Journal of Cardiology, 152(2), 258-259. [More Information]
  • Gray, B., MacDonald, P., Kuchar, D. (2011). Reversal of cardiomyopathy with ivabradine. Internal Medicine Journal, 41(2), 213-214. [More Information]
Back to Top

To update your profile click here. For support on your academic profile contact .